Glutamine supplementation reduced the oxidative status of the liver and inhibited NF-κB expression, in association with improvement of hepatic steatosis, suggesting a protective effect of glutamine in NAFLD [58]. The gene discussed is NFKB1; the disease is fatty liver disease.